Deric Park to Meningioma
This is a "connection" page, showing publications Deric Park has written about Meningioma.
Connection Strength
1.297
-
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK. JCI Insight. 2019 10 17; 4(20).
Score: 0.691
-
LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Cancer Lett. 2018 02 28; 415:217-226.
Score: 0.606